Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC

NCT06846450 is registered in ClinicalTrials.gov with Lin Kong, MD as lead sponsor.

NCT NCT06846450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06846450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC
Lead sponsor
Lin Kong, MD
Phase
Phase 3
Overall status
Recruiting
Start date
April 1, 2025
Completion date
January 31, 2031
Enrollment
470 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal cancinoma (npc)